These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 6582805

  • 1. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
    Umeda T, Takada N, Hodaka E, Endoh F, Ishii T.
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):285-94. PubMed ID: 6582805
    [Abstract] [Full Text] [Related]

  • 2. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G, Ferrari S, Longhi A, Forni C, Loro L, Beghelli C, Tremosini M, Versari M.
    Oncol Rep; 2003 Feb; 10(4):851-7. PubMed ID: 12792734
    [Abstract] [Full Text] [Related]

  • 3. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.
    Cancer; 2004 Apr 15; 100(8):1724-33. PubMed ID: 15073863
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H, Farré R, Soy D, Peraire C, Cendros JM, Pardo N, Torrent M, Domenech J, Mangues MA.
    Ther Drug Monit; 2009 Feb 15; 31(1):76-85. PubMed ID: 19077931
    [Abstract] [Full Text] [Related]

  • 5. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K, Matsuoka H, Murakami T, Fujimoto T, Takayanagi F, Sawai K, Niwa J, Hara K.
    Gan To Kagaku Ryoho; 1986 May 15; 13(5):1837-45. PubMed ID: 3486634
    [Abstract] [Full Text] [Related]

  • 6. [Preliminary evaluation of individualized use of large doses of methotrexate for treatment of osteosarcoma in children and adolescents].
    Perek D, Jurczyk-Procyk S, Prokopczyk J, Piekarczyk A, Zelazowski J, Dembowska-Bagińska B, Wieckowska J, Witkowska-Ozogowska J, Kozera M.
    Pediatr Pol; 1995 Nov 15; 70(11):929-37. PubMed ID: 8677159
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
    Perez C, Wang YM, Sutow WW, Herson J.
    Cancer Clin Trials; 1978 Nov 15; 1(2):107-11. PubMed ID: 316368
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preoperative administration of high-dose methotrexate for osteosarcoma.
    Chan KW, Knowling MA, Duncan CP, Morton KS.
    Can J Surg; 1984 May 15; 27(3):305-7, 309. PubMed ID: 6586272
    [Abstract] [Full Text] [Related]

  • 13. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J, Kralovánszky J, Adleff V, Pap E, Németh K, Komlósi V, Kovács G.
    Anticancer Res; 2008 May 15; 28(5B):3051-4. PubMed ID: 19031955
    [Abstract] [Full Text] [Related]

  • 14. High dose methotrexate in adult patients with osteosarcoma: clinical and pharmacokinetic results.
    Comandone A, Passera R, Boglione A, Tagini V, Ferrari S, Cattel L.
    Acta Oncol; 2005 May 15; 44(4):406-11. PubMed ID: 16120550
    [Abstract] [Full Text] [Related]

  • 15. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S, Kellick M, Wexler LH, Gorlick R, Meyers PA.
    Pediatr Blood Cancer; 2008 Jun 15; 50(6):1176-80. PubMed ID: 18266225
    [Abstract] [Full Text] [Related]

  • 16. Anaphylactoid reaction to high-dose methotrexate and successful desensitization.
    Oulego-Erroz I, Maneiro-Freire M, Bouzón-Alejandro M, Vázquez-Donsión M, Couselo JM.
    Pediatr Blood Cancer; 2010 Sep 15; 55(3):557-9. PubMed ID: 20533520
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
    Davis KA, Williams P, Walker JC.
    Ann Allergy Asthma Immunol; 2003 Jan 15; 90(1):87-9. PubMed ID: 12546343
    [Abstract] [Full Text] [Related]

  • 19. [High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients].
    Wang QL, Sun Y, Zhou JC, Song SZ, Feng FY, Lu L, Yie ZS.
    Zhonghua Zhong Liu Za Zhi; 1988 Mar 15; 10(2):152-4. PubMed ID: 3264785
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.